ArticleBritish journal of pharmacology2017

Morin, a novel liver X receptor α/β dual antagonist, has potent therapeutic efficacy for nonalcoholic fatty liver diseases.

Ming Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.